Sexually Transmitted Disease Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently released a comprehensive report on the global Sexually Transmitted Disease (STD) Testing Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This report offers valuable insights into the current market structure and future growth prospects, aiding stakeholders in making informed decisions.

Key Insights:

STD Testing Market Size (2024E): US$10.03 Bn
Projected Market Value (2031F): US$17.08 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 7.9%

STD Testing Market - Report Scope:

The STD Testing market includes diagnostic tests for sexually transmitted infections such as HIV, syphilis, gonorrhea, chlamydia, and human papillomavirus (HPV). The growing prevalence of STDs, increased public health awareness, and improved access to healthcare services are key factors driving the demand for STD testing. This market also includes various testing methods such as laboratory-based testing, point-of-care testing, and rapid diagnostics. The increasing acceptance of self-testing kits and technological advancements in diagnostic tools further support market growth.

Market Growth Drivers:

Several factors are driving the growth of the global STD Testing market. Rising awareness about sexual health, increased government initiatives for STD prevention, and growing incidences of sexually transmitted infections are key contributors. The expansion of healthcare infrastructure, the availability of advanced diagnostic tools, and increasing demand for early detection and treatment of STDs also propel market growth. Additionally, the integration of telemedicine and digital health platforms for testing and consultation services is further accelerating market adoption.

Market Restraints:

Despite the positive growth outlook, the STD Testing market faces several challenges. Social stigma and lack of awareness about STDs in certain regions hinder testing adoption. In low-resource settings, limited access to testing services and high costs associated with some diagnostic procedures also pose challenges. The variation in regulations across regions and the need for specialized healthcare infrastructure may also restrict market growth in some areas.

Market Opportunities:

The STD Testing market offers significant opportunities for growth, driven by advancements in diagnostic technologies and increasing demand for self-testing kits. The development of rapid point-of-care diagnostic tests and home-based testing solutions are opening new avenues for market expansion. Collaborations between healthcare providers, diagnostic companies, and public health organizations can further enhance testing outreach and accessibility. Additionally, rising investments in sexual health awareness campaigns and research initiatives to combat the spread of STDs present new growth opportunities for companies in this market.

Key Questions Answered in the Report:

What are the primary factors driving the global growth of the STD Testing market?
Which regions and market segments are experiencing the highest demand for STD testing services?
How are technological advancements in diagnostics impacting the competitive landscape of the STD Testing market?
Who are the major players in the STD Testing market, and what strategies are they employing to maintain their market positions?
What are the emerging trends and future outlooks for the global STD Testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global STD Testing market, including Abbott Laboratories, F. Hoffmann-La Roche Ltd, and bioMerieux SA, are focusing on technological innovation, expanding their product portfolios, and forming strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic tools, such as rapid tests and molecular diagnostics, to meet the growing demand for accurate and timely STD testing. Collaborations with healthcare providers, public health organizations, and government bodies are essential for increasing testing accessibility and promoting early detection initiatives.

Key Companies Profiled:

BD
F. Hoffmann-La Roche Ltd
Hologic Inc.
Abbott
Cepheid (Danaher)
Qiagen
OraSure Technologies, Inc.
Bio-Rad Laboratories, Inc.
bioMerieux SA
Thermo Fisher Scientific, Inc.
Seegene Inc.
DiaSorin S.P.A

STD Testing Industry Research by Category:

By Product

Instruments & Services
Consumables
Software

By Application

CT/NG Testing
Syphilis Testing
HSV Testing

By Technology

Immunoassay
Molecular Diagnostics

By Region

North America
Latin America
Europe
South Asia & Oceania
East Asia
The Middle East & Africa

Product Code: PMRREP34842

1. Executive Summary

1.1. Global Sexually Transmitted Disease Testing Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global GDP Growth Outlook
- 2.3.2. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Product Adoption Analysis
3.2. Disease Epidemiology
3.3. Regulatory Landscape
3.4. Value Chain Analysis
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter's Five Force Analysis

4. Global Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

4.1. Global Sexually Transmitted Disease Testing Market Outlook: Product
- 4.1.1. Introduction / Key Findings
- 4.1.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2023
- 4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
  - 4.1.3.1. Instruments & Services
  - 4.1.3.2. Consumables
  - 4.1.3.3. Software
4.2. Market Attractiveness Analysis: Product
4.3. Global Sexually Transmitted Disease Testing Market Outlook: Application
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
- 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  - 4.3.3.1. CT/NG Testing
  - 4.3.3.2. Syphilis Testing
  - 4.3.3.3. HSV Testing
4.4. Market Attractiveness Analysis: Application
4.5. Global Sexually Transmitted Disease Testing Market Outlook: Technology
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2023
- 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
  - 4.5.3.1. Immunoassay
  - 4.5.3.2. Molecular Diagnostics
4.6. Market Attractiveness Analysis: Technology

5. Global Sexually Transmitted Disease Testing Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 6.3.1. By Country
- 6.3.2. By Product
- 6.3.3. By Application
- 6.3.4. By Technology
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 6.4.1. U.S.
- 6.4.2. Canada
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
- 6.5.1. Instruments & Services
- 6.5.2. Consumables
- 6.5.3. Software
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 6.6.1. CT/NG Testing
- 6.6.2. Syphilis Testing
- 6.6.3. HSV Testing
6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
- 6.7.1. Immunoassay
- 6.7.2. Molecular Diagnostics
6.8. Market Attractiveness Analysis

7. Europe Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 7.3.1. By Country
- 7.3.2. By Product
- 7.3.3. By Application
- 7.3.4. By Technology
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 7.4.1. Germany
- 7.4.2. France
- 7.4.3. U.K.
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Turkiye
- 7.4.8. Rest of Europe
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
- 7.5.1. Instruments & Services
- 7.5.2. Consumables
- 7.5.3. Software
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 7.6.1. CT/NG Testing
- 7.6.2. Syphilis Testing
- 7.6.3. HSV Testing
7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
- 7.7.1. Immunoassay
- 7.7.2. Molecular Diagnostics
7.8. Market Attractiveness Analysis

8. East Asia Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 8.3.1. By Country
- 8.3.2. By Product
- 8.3.3. By Application
- 8.3.4. By Technology
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. South Korea
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
- 8.5.1. Instruments & Services
- 8.5.2. Consumables
- 8.5.3. Software
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 8.6.1. CT/NG Testing
- 8.6.2. Syphilis Testing
- 8.6.3. HSV Testing
8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
- 8.7.1. Immunoassay
- 8.7.2. Molecular Diagnostics
8.8. Market Attractiveness Analysis

9. South Asia & Oceania Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 9.3.1. By Country
- 9.3.2. By Product
- 9.3.3. By Application
- 9.3.4. By Technology
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 9.4.1. India
- 9.4.2. Southeast Asia
- 9.4.3. ANZ
- 9.4.4. Rest of South Asia & Oceania
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
- 9.5.1. Instruments & Services
- 9.5.2. Consumables
- 9.5.3. Software
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 9.6.1. CT/NG Testing
- 9.6.2. Syphilis Testing
- 9.6.3. HSV Testing
9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
- 9.7.1. Immunoassay
- 9.7.2. Molecular Diagnostics
9.8. Market Attractiveness Analysis

10. Latin America Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 10.3.1. By Country
- 10.3.2. By Product
- 10.3.3. By Application
- 10.3.4. By Technology
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 10.4.1. Brazil
- 10.4.2. Mexico
- 10.4.3. Rest of Latin America
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
- 10.5.1. Instruments & Services
- 10.5.2. Consumables
- 10.5.3. Software
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 10.6.1. CT/NG Testing
- 10.6.2. Syphilis Testing
- 10.6.3. HSV Testing
10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
- 10.7.1. Immunoassay
- 10.7.2. Molecular Diagnostics
10.8. Market Attractiveness Analysis

11. Middle East & Africa Sexually Transmitted Disease Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
- 11.3.1. By Country
- 11.3.2. By Product
- 11.3.3. By Application
- 11.3.4. By Technology
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
- 11.4.1. GCC Countries
- 11.4.2. Egypt
- 11.4.3. South Africa
- 11.4.4. Northern Africa
- 11.4.5. Rest of Middle East & Africa
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
- 11.5.1. Instruments & Services
- 11.5.2. Consumables
- 11.5.3. Software
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
- 11.6.1. CT/NG Testing
- 11.6.2. Syphilis Testing
- 11.6.3. HSV Testing
11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2031
- 11.7.1. Immunoassay
- 11.7.2. Molecular Diagnostics
11.8. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2024
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. BD
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. F. Hoffmann-La Roche Ltd
- 12.3.3. Hologic Inc.
- 12.3.4. Abbott
- 12.3.5. Cepheid (Danaher)
- 12.3.6. Qiagen
- 12.3.7. OraSure Technologies, Inc.
- 12.3.8. Bio-Rad Laboratories, Inc.
- 12.3.9. bioMerieux SA
- 12.3.10. Thermo Fisher Scientific, Inc.
- 12.3.11. Seegene Inc.
- 12.3.12. DiaSorin S.P.A
- 12.3.13. Others

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations